HENRY J FUCHS
CIK 1197355 · President, Worldwide R&D · last filed 2024-09-17
HENRY J FUCHS is a President, Worldwide R&D who has filed 195 SEC Form 4 insider transactions across 5 companies since 2007. The most recent filing, for BMRN, was dated Sep 17, 2024. Across all open-market trades the lifetime net is −$76.6M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $11.8M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$11.81M
5
195
-$76.63M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BMRN | President, Worldwide R&D | 185,074 | $63.81 | $11.81M | -$62.29M | 112 | 2024-09-17 |
| Mirati Therapeutics, Inc. (MRTX) Delisted | Director | 10,465 | $58.70 | $614.3K | -$4.81M | 13 | 2023-01-24 |
| GENOMIC HEALTH INC (GHDX) Delisted | Director | 7,833 | — | — | -$2.45M | 29 | 2019-10-03 |
| Ardea Biosciences, Inc./DE (RDEA) Delisted | Director | 0 | — | — | -$1.73M | 20 | 2012-06-20 |
| ONYX PHARMACEUTICALS INC (ONXX) Delisted | EVP & Chief Medical Officer | 14,891 | — | — | -$5.36M | 17 | 2008-11-19 |
Recent Filings
195 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-09-17 | BMRN | Mixed | −11,798 | -$1.01M | EDGAR |
| 2024-03-19 | BMRN | Mixed | −15,245 | -$2.81M | EDGAR |
| 2024-03-07 | BMRN | Sell (S) | −35,341 | -$3.01M | EDGAR |
| 2024-03-05 | BMRN | Notice (144) | −35,341 | -$3.01M | EDGAR |
| 2024-02-29 | BMRN | Grant (A) | +53,204 | $0 | EDGAR |
| 2023-12-05 | BMRN | Grant (A) | +18,067 | $21.2K | EDGAR |
| 2023-08-11 | BMRN | Sell (S) | −12,000 | -$1.09M | EDGAR |
| 2023-08-10 | BMRN | Notice (144) | −12,000 | -$1.09M | EDGAR |
| 2023-03-17 | BMRN | Mixed | −23,959 | -$3.78M | EDGAR |
| 2023-03-02 | BMRN | Grant (A) | +68,052 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.